Unit
Division of Infectious Diseases, Infection Prevention and Travel Medicine
INFEKT · Dept. I
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients
Maraolo A, Daikos G, Vardakas K, Roilides E, Uhlemann A, Ghafur A, Mornese Pinna S, Bassetti M, Kohler P, Rahav G, Villegas M, Veeraraghavan B, Corcione S, Grossi A, Signori A, Alicino C, Hussein K, Trecarichi E, Viale P, Timsit J, Giacobbe D. The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients. Infect Dis Ther 2021
Feb 14, 2021The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients
Feb 14, 2021Infect Dis Ther 2021
Maraolo Alberto E, Daikos George L, Vardakas Konstantinos Z, Roilides Emmanuel, Uhlemann Anne-Catrin, Ghafur Abdul K, Mornese Pinna Simone, Bassetti Matteo, Kohler Philipp, Rahav Galia, Villegas Maria V, Veeraraghavan Balaji, Corcione Silvia, Grossi Adriano, Signori Alessio, Alicino Cristiano, Hussein Khetam, Trecarichi Enrico M, Viale Pierluigi, Timsit Jean-François, Giacobbe Daniele R
Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases
Sawatzki M, Gueller U, Güsewell S, Husarik D, Semela D, Brand S. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases. J Hepatol 2021; 74:419-427.
Feb 12, 2021Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases
Feb 12, 2021J Hepatol 2021; 74:419-427
Sawatzki Mikael, Gueller Ulrich, Güsewell Sabine, Husarik Daniela B., Semela David, Brand Stephan
In-depth analysis of the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) - The importance of representation of medical specialty and geographic regions
Pratsinis M, Halabi S, Güsewell S, Gillessen S, Omlin A. In-depth analysis of the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) - The importance of representation of medical specialty and geographic regions. Eur Urol Open Sci 2021; 26:14-17.
Feb 12, 2021In-depth analysis of the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) - The importance of representation of medical specialty and geographic regions
Feb 12, 2021Eur Urol Open Sci 2021; 26:14-17
Pratsinis Manolis, Halabi Susan, Güsewell Sabine, Gillessen Silke, Omlin Aurelius
An unusual case of multiple hepatic and pulmonary abscesses caused by Aggregatibacter aphrophilus in a young man: a case report
Sumer J, Haller S, Sawatzki M, Kellner J, Boggian K. An unusual case of multiple hepatic and pulmonary abscesses caused by Aggregatibacter aphrophilus in a young man: a case report. J Med Case Rep 2021; 15:34.
Feb 4, 2021An unusual case of multiple hepatic and pulmonary abscesses caused by Aggregatibacter aphrophilus in a young man: a case report
Feb 4, 2021J Med Case Rep 2021; 15:34
Sumer Johannes, Haller Sabine, Sawatzki Mikael, Kellner Jan, Boggian Katia
HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors - a case report
Sumer J, Waldeck F, Fischer N, Appenzeller C, Koster M, Früh M, Albrich W. HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors - a case report. Pneumonia (Nathan) 2021; 13:1.
Jan 25, 2021HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors - a case report
Jan 25, 2021Pneumonia (Nathan) 2021; 13:1
Sumer Johannes, Waldeck Frederike, Fischer Nadja, Appenzeller Christina, Koster Markus, Früh Martin, Albrich Werner
The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections
Kusejko K, Ferrari M, Gassmann N, Sendi P, Jent P, Morand P, Vijayvargiya P, Trebše R, Patel R, Kouyos R, Corvec S, Kramer T, Stadelmann V, Wouthuyzen-Bakker M, Fernandez-Sampedro M, Clauss M, Auñón Á, Jost B, Benito N, Strahm C, Thurnheer C, Pablo-Marcos D, Slama D, Scanferla G, Uçkay I, Waldmann I, Esteban J, Lora-Tamayo J, Achermann Y. The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections. Clin Infect Dis 2021; 72:e1064-e1073.
Jan 15, 2021The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections
Jan 15, 2021Clin Infect Dis 2021; 72:e1064-e1073
Kusejko Katharina, Ferrari Matteo Carlo, Gassmann Natalie, Sendi Parham, Jent Philipp, Morand Philippe C, Vijayvargiya Prakhar, Trebše Rihard, Patel Robin, Kouyos Roger D, Corvec Stéphane, Kramer Tobias Siegfried, Stadelmann Vincent A, Wouthuyzen-Bakker Marjan, Fernandez-Sampedro Marta, Clauss Martin, Auñón Álvaro, Jost Bernhard, Benito Natividad, Strahm Carol, Thurnheer Christine, Pablo-Marcos Daniel, Slama Dorsaf, Scanferla Giulia, Uçkay Ilker, Waldmann Isabelle, Esteban Jaime, Lora-Tamayo Jaime, Achermann Yvonne
The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study
Surial B, Wandeler G, Furrer H, Rauch A, Schmid P, Bernasconi E, Stöckle M, Günthard H, Calmy A, Darling K, Daeppen J, Bertholet N, the Swiss HIV Cohort Study. The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study. J Clin Med 2021; 10
Jan 14, 2021The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study
Jan 14, 2021J Clin Med 2021; 10
Surial Bernard, Wandeler Gilles, Furrer Hansjakob, Rauch Andri, Schmid Patrick, Bernasconi Enos, Stöckle Marcel, Günthard Huldrych F, Calmy Alexandra, Darling Katharine E A, Daeppen Jean-Bernard, Bertholet Nicolas, the Swiss HIV Cohort Study
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
Weber M, Imperiali M, Salimi Y, Fleisch F, Cusini A, Heer S, Renz H, Paprotny M, Kohler P, Vernazza P, Risch L, Bodmer T, Egli K, Risch M, Thiel S, Grossmann K, Nigg S, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Kahlert C. Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Dis Markers 2021; 2021:8810196.
Jan 6, 2021Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
Jan 6, 2021Dis Markers 2021; 2021:8810196
Weber Myriam C, Imperiali Mauro, Salimi Yacir, Fleisch Felix, Cusini Alexia, Heer Sonja, Renz Harald, Paprotny Matthias, Kohler Philipp, Vernazza Pietro, Risch Lorenz, Bodmer Thomas, Egli Konrad, Risch Martin, Thiel Sarah L, Grossmann Kirsten, Nigg Susanne, Wohlwend Nadia, Lung Thomas, Hillmann Dorothea, Ritzler Michael, Ferrara Francesca, Bigler Susanna, Kahlert Christian
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Urwyler P, Sendi P, Albrich W, Stüssi-Helbling M, Huber L, Bacci M, Camacho-Ortiz A, Sumer J, Thoma R, Trendelenburg M, Heijnen I, Moser S, Charitos P, Osthoff M. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Trials 2021; 22:1.
Jan 4, 2021Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Jan 4, 2021Trials 2021; 22:1
Urwyler Pascal, Sendi Parham, Albrich Werner, Stüssi-Helbling Melina, Huber Lars C, Bacci Marcelo R, Camacho-Ortiz Adrián, Sumer Johannes, Thoma Reto, Trendelenburg Marten, Heijnen Ingmar A F M, Moser Stephan, Charitos Panteleimon, Osthoff Michael
Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Hasan Ali O, Penninger J, Bergthaler A, Popa A, Gómez-Mejia A, Schüpbach R, Bühler P, Vernazza P, Kahlert C, Kohler P, Albrich W, Kern L, Thiel S, Weber M, Paprotny M, Brugger S, Risch L, Bomze D, Flatz L. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:e2869-e2874.
Jan 2, 2021Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Jan 2, 2021Clin Infect Dis 2021; 73:e2869-e2874
Hasan Ali Omar, Penninger Josef M, Bergthaler Andreas, Popa Alexandra M, Gómez-Mejia Alejandro, Schüpbach Reto A, Bühler Philipp K, Vernazza Pietro, Kahlert Christian, Kohler Philipp, Albrich Werner, Kern Lukas, Thiel Sarah, Weber Myriam, Paprotny Matthias, Brugger Silvio D, Risch Lorenz, Bomze David, Flatz Lukas
Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study
Schoepf I, Tarr P, Fellay J, Günthard H, Kouyos R, Buvelot H, Cavassini M, Bernasconi E, Seneghini M, Thurnheer C, Marzolini C, Hasse B, Reiss P, Kootstra N, Raffenberg M, Engel T, Ledergerber B, Thorball C, Swiss HIV Cohort Study. Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study. Clin Infect Dis 2021; 73:1597-1604.
Jan 2, 2021Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study
Jan 2, 2021Clin Infect Dis 2021; 73:1597-1604
Schoepf Isabella C, Tarr Philip E, Fellay Jacques, Günthard Huldrych F, Kouyos Roger, Buvelot Hélène, Cavassini Matthias, Bernasconi Enos, Seneghini Marco, Thurnheer Christine, Marzolini Catia, Hasse Barbara, Reiss Peter, Kootstra Neeltje A, Raffenberg Marieke, Engel Tanja, Ledergerber Bruno, Thorball Christian W, Swiss HIV Cohort Study
Acute respiratory distress syndrome during the COVID-19 pandemic: not only SARS-CoV-2
Meyer Sauteur P, Kleger G, Albrich W. Acute respiratory distress syndrome during the COVID-19 pandemic: not only SARS-CoV-2. New Microbes New Infect 2021; 40:100836.
Jan 1, 2021Acute respiratory distress syndrome during the COVID-19 pandemic: not only SARS-CoV-2
Jan 1, 2021New Microbes New Infect 2021; 40:100836
Meyer Sauteur P M, Kleger Gian-Reto, Albrich Werner
Outcome groups and a practical tool to predict success of shock wave lithotripsy in daily clinical routine
Hirsch B, Wildermuth S, Schmid H, Vetterlein M, Pratsinis M, Betschart P, Langenauer J, Güsewell S, Abt D, Zumstein V. Outcome groups and a practical tool to predict success of shock wave lithotripsy in daily clinical routine. World J Urol 2021; 39:943-51.
Jan 1, 2021Outcome groups and a practical tool to predict success of shock wave lithotripsy in daily clinical routine
Jan 1, 2021World J Urol 2021; 39:943-51
Hirsch B, Wildermuth Simon, Schmid Hans-Peter, Vetterlein MW, Pratsinis Manolis, Betschart Patrick, Langenauer Janine, Güsewell Sabine, Abt Dominik, Zumstein Valentin
Reduction of stent-associated morbidity by minimizing stent material: a prospective, randomized, single-blind superiority trial assessing a customized "suture stent"
Betschart P, Piller A, Zumstein V, Schmid H, Engeler D, Güsewell S, Pratsinis M, Abt D. Reduction of stent-associated morbidity by minimizing stent material: a prospective, randomized, single-blind superiority trial assessing a customized "suture stent". BJU Int 2021; 127:596-605.
Jan 1, 2021Reduction of stent-associated morbidity by minimizing stent material: a prospective, randomized, single-blind superiority trial assessing a customized "suture stent"
Jan 1, 2021BJU Int 2021; 127:596-605
Betschart Patrick, Piller A, Zumstein Valentin, Schmid Hans-Peter, Engeler Daniel, Güsewell Sabine, Pratsinis Manolis, Abt Dominik
Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasie in medium-to-large-sized prostates (AHTLETE): protocol of a prospective randomised trial
Muellhaupt G, Güsewell S, Schmid H, Zumstein V, Betschart P, Engeler D, Abt D. Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasie in medium-to-large-sized prostates (AHTLETE): protocol of a prospective randomised trial. BMJ Open 2021; 11
Jan 1, 2021Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasie in medium-to-large-sized prostates (AHTLETE): protocol of a prospective randomised trial
Jan 1, 2021BMJ Open 2021; 11
Muellhaupt Gautier, Güsewell Sabine, Schmid Hans-Peter, Zumstein Valentin, Betschart Patrick, Engeler Daniel, Abt Dominik
Radiation exposure during prostatic artery embolisation: a systematic review and calculation of associated risks
Zumstein V, Binder J, Güsewell S, Betschart P, Pratsinis M, Muellhaupt G, Hechelhammer L, Schmid H, Abt D. Radiation exposure during prostatic artery embolisation: a systematic review and calculation of associated risks. Eur Urol Focus 2021; 7:608-11.
Jan 1, 2021Radiation exposure during prostatic artery embolisation: a systematic review and calculation of associated risks
Jan 1, 2021Eur Urol Focus 2021; 7:608-11
Zumstein Valentin, Binder J, Güsewell Sabine, Betschart Patrick, Pratsinis Manolis, Muellhaupt Gautier, Hechelhammer Lukas, Schmid Hans-Peter, Abt Dominik
The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women
Vernazza P, Risch L, Lange K, Esson C, Hauser C, Aebi-Popp K, Stoffel M, Dost F, Ritzler M, Rasi M, Schmidt A. The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women. Swiss Med Wkly 2020; 150:w20393.
Dec 31, 2020The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women
Dec 31, 2020Swiss Med Wkly 2020; 150:w20393
Vernazza Pietro, Risch Lorenz, Lange Katharina, Esson Cate, Hauser Christoph V, Aebi-Popp Karoline, Stoffel Milena, Dost Ferah, Ritzler Michael, Rasi Manuela, Schmidt Axel Jeremias
The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of men
Schmidt A, Konrad T, Lange K, Lehner A, Jouinot F, Stöckle M, Hauser C, Lung T, Ritzler M, Christinet V, Esson C, Rasi M, Vernazza P. The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of men. Swiss Med Wkly 2020; 150:w20392.
Dec 31, 2020The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of men
Dec 31, 2020Swiss Med Wkly 2020; 150:w20392
Schmidt Axel Jeremias, Konrad Torsten, Lange Katharina, Lehner Andreas, Jouinot Florent, Stöckle Marcel, Hauser Christoph V, Lung Thomas, Ritzler Michael, Christinet Vanessa, Esson Cate, Rasi Manuela, Vernazza Pietro
Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission
Reichmuth M, Kouyos R, Kusejko K, Günthard H, Bernasconi E, Cavassini M, Vernazza P, Ramette A, Hauser C, Hirsch H, Yerly S, Klimkait T, Perreau M, Metzner K, Böni J, Nguyen H, Bachmann N, Chaudron S, Swiss HIV Cohort Study. Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission. HIV Med 2020
Dec 25, 2020Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission
Dec 25, 2020HIV Med 2020
Reichmuth M L, Kouyos R D, Kusejko K, Günthard H F, Bernasconi E, Cavassini M, Vernazza Pietro, Ramette A, Hauser C, Hirsch H H, Yerly S, Klimkait T, Perreau M, Metzner K J, Böni J, Nguyen H, Bachmann N, Chaudron S E, Swiss HIV Cohort Study
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland
Moccia A, Mingrone W, Novak U, Pfleger C, Richter P, Rütti M, Schmidt A, Stenner F, Voegeli M, Zander T, Zucca E, Mey U, Lang N, Aeppli S, Güsewell S, Bargetzi M, Caspar C, Brülisauer D, Ebnöther M, Fehr M, Fischer N, Ghilardi G, Krasniqi F, Hitz F. Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland. Hematol Oncol 2020; 39:196-204.
Dec 23, 2020Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland
Dec 23, 2020Hematol Oncol 2020; 39:196-204
Moccia A A, Mingrone W, Novak U, Pfleger C, Richter P, Rütti M, Schmidt A, Stenner F, Voegeli M, Zander T, Zucca E, Mey U, Lang N, Aeppli Stefanie, Güsewell Sabine, Bargetzi M, Caspar C, Brülisauer D, Ebnöther M, Fehr Martin, Fischer N, Ghilardi G, Krasniqi F, Hitz Felicitas